• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy of individualized homeopathy as an adjunct to standard of care of COVID-19: A randomized, single-blind, placebo-controlled study.

作者信息

Nayak Debadatta, Gupta Juhi, Chaudhary Anupriya, Singh Krishna Gopal, Deshmukh Abhijeet, Das Deblina, Saha Abhishek, Kumar Deepak, Kumar Ashwini, Goenka Ajay, Mishra S K, Gupta Sanjay, Khurana Anil

机构信息

Epidemic Cell, Central Council for Research in Homoeopathy, 61-65, Institutional Area, Janakpuri, New Delhi, 110058, India.

Dept. of Physiology, Government Homoeopathic Medical College and Hospital, AYUSH Campus, MACT Hills, Kaliasot Dam Approach Rd, Chuna Bhatti, Bhopal, Madhya Pradesh, 462003, India.

出版信息

Complement Ther Clin Pract. 2022 Aug;48:101602. doi: 10.1016/j.ctcp.2022.101602. Epub 2022 May 8.

DOI:10.1016/j.ctcp.2022.101602
PMID:35569230
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC9080028/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92a/9080028/439d56304081/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92a/9080028/3257243795ba/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92a/9080028/f839539919c3/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92a/9080028/daef126c5e9e/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92a/9080028/19306845417e/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92a/9080028/439d56304081/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92a/9080028/3257243795ba/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92a/9080028/f839539919c3/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92a/9080028/daef126c5e9e/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92a/9080028/19306845417e/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92a/9080028/439d56304081/gr5_lrg.jpg

相似文献

1
Efficacy of individualized homeopathy as an adjunct to standard of care of COVID-19: A randomized, single-blind, placebo-controlled study.个性化顺势疗法作为新冠肺炎标准治疗辅助手段的疗效：一项随机、单盲、安慰剂对照研究。
Complement Ther Clin Pract. 2022 Aug;48:101602. doi: 10.1016/j.ctcp.2022.101602. Epub 2022 May 8.
2
Homeopathy as an Adjuvant to Standard Care in Moderate and Severe Cases of COVID-19: A Single-Blind, Randomized, Placebo-Controlled Study.顺势疗法作为 COVID-19 中重度病例标准治疗的辅助手段：一项单盲、随机、安慰剂对照研究。
Homeopathy. 2023 Aug;112(3):184-197. doi: 10.1055/s-0042-1755365. Epub 2022 Nov 28.
3
Homeopathy for Covid-19 in Primary Care: A structured summary of a study protocol for a randomized controlled trial.基层医疗中顺势疗法治疗 COVID-19：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Feb 1;22(1):109. doi: 10.1186/s13063-021-05071-5.
4
Homeopathic treatment in addition to standard care in multi drug resistant pulmonary tuberculosis: a randomized, double blind, placebo controlled clinical trial.顺势疗法联合标准治疗用于耐多药肺结核：一项随机、双盲、安慰剂对照临床试验
Homeopathy. 2014 Apr;103(2):97-107. doi: 10.1016/j.homp.2013.12.003.
5
Efficacy of Individualized Homeopathic Medicines in the Treatment of Atopic Dermatitis in Adults: A Double-Blind, Randomized, Placebo-Controlled, Preliminary Trial.个体化顺势疗法制剂治疗成人特应性皮炎的疗效：一项双盲、随机、安慰剂对照、初步试验。
Complement Med Res. 2022;29(1):17-26. doi: 10.1159/000516026. Epub 2021 Apr 15.
6
Beyond pharmaceuticals: The untapped potential of homeopathy in the battle against COVID-19.超越药物：顺势疗法在抗击新冠疫情中的未开发潜力
Explore (NY). 2023 Nov-Dec;19(6):868-870. doi: 10.1016/j.explore.2023.04.002. Epub 2023 Apr 5.
7
Randomized Double-Blind, Placebo-Controlled Feasibility Study, Evaluating the Efficacy of Homeopathic Medicines in the Prevention of COVID-19 in a Quarantined Population.随机双盲、安慰剂对照可行性研究，评估顺势疗法药物在隔离人群中预防 COVID-19 的效果。
Homeopathy. 2022 Feb;111(1):49-56. doi: 10.1055/s-0041-1735235. Epub 2021 Sep 30.
8
A double-blind randomized placebo-controlled feasibility study evaluating individualized homeopathy in managing pain of knee osteoarthritis.一项双盲随机安慰剂对照可行性研究，评估个体化顺势疗法对膝关节骨关节炎疼痛的管理效果。
J Evid Based Complementary Altern Med. 2015 Jul;20(3):186-91. doi: 10.1177/2156587214568668. Epub 2015 Jan 30.
9
Efficacy of individualized homeopathic medicines in intervening with the progression of pre-hypertension to hypertension: A double-blind, randomized, placebo-controlled trial.个体化顺势疗法药物干预高血压前期进展为高血压的疗效：一项双盲、随机、安慰剂对照试验。
Explore (NY). 2022 May-Jun;18(3):279-286. doi: 10.1016/j.explore.2021.05.007. Epub 2021 Jun 5.
10
Double-blind evaluation of homeopathy on cocaine craving: a randomized controlled pilot study.双盲评估顺势疗法对可卡因渴望的影响：一项随机对照的初步研究。
J Integr Med. 2018 May;16(3):178-184. doi: 10.1016/j.joim.2018.03.004. Epub 2018 Mar 30.

引用本文的文献

1
Management of Patients With COVID-19 During the Pandemic: A Retrospective Cohort Study From a Tertiary Care Centre in Mumbai, India.疫情期间新冠病毒病患者的管理：来自印度孟买一家三级医疗中心的回顾性队列研究
Cureus. 2025 May 8;17(5):e83711. doi: 10.7759/cureus.83711. eCollection 2025 May.
2
Randomised controlled trial to compare efficacy of standard care alone and in combination with homoeopathic treatment of moderate/severe COVID-19 cases.随机对照试验比较单独使用标准护理与联合顺势疗法治疗中度/重度 COVID-19 病例的疗效。
PLoS One. 2023 Nov 15;18(11):e0292783. doi: 10.1371/journal.pone.0292783. eCollection 2023.
3

本文引用的文献

1
Adjunctive homeopathic treatment of hospitalized COVID-19 patients (COVIHOM): A retrospective case series.辅助顺势疗法治疗住院 COVID-19 患者（COVIHOM）：回顾性病例系列。
Complement Ther Clin Pract. 2021 Aug;44:101415. doi: 10.1016/j.ctcp.2021.101415. Epub 2021 May 11.
2
Clinical Repurposing of Medicines is Intrinsic to Homeopathy: Research Initiatives on COVID-19 in India.临床药物再利用是顺势疗法的固有特性：印度对 COVID-19 的研究计划。
Homeopathy. 2021 Aug;110(3):198-205. doi: 10.1055/s-0041-1725988. Epub 2021 Apr 14.
3
Drug repurposing approach to fight COVID-19.
Strange, Rare and Peculiar Symptoms of COVID-19 Cases Managed by Practitioners of the Homeopathy Help Network.
《顺势疗法帮助网络医生管理的 COVID-19 病例的奇怪、罕见和特殊症状》。
Homeopathy. 2024 May;113(2):112-125. doi: 10.1055/s-0043-1771374. Epub 2023 Nov 1.
4
Immunological Responses of Arsenicum album 30CH to Combat COVID-19: Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial in the Pathanamthitta District of Kerala.30CH 白砷对抗击 COVID-19 的免疫反应：喀拉拉邦帕塔南蒂塔区双盲、随机、安慰剂对照临床试验方案
JMIR Res Protoc. 2023 Oct 16;12:e48479. doi: 10.2196/48479.
药物重定位方法抗击 COVID-19。
Pharmacol Rep. 2020 Dec;72(6):1479-1508. doi: 10.1007/s43440-020-00155-6. Epub 2020 Sep 5.
4
Persistent Symptoms in Patients After Acute COVID-19.急性 COVID-19 后患者的持续症状。
JAMA. 2020 Aug 11;324(6):603-605. doi: 10.1001/jama.2020.12603.
5
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.COVID-19 中的细胞因子风暴：趋化因子/趋化因子受体系统的参与概述。
Cytokine Growth Factor Rev. 2020 Jun;53:25-32. doi: 10.1016/j.cytogfr.2020.05.003. Epub 2020 May 11.
6
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study.预测 SARS-CoV-2 引起的 COVID-19 肺炎患者死亡率的前瞻性队列研究。
Eur Respir J. 2020 May 7;55(5). doi: 10.1183/13993003.00524-2020. Print 2020 May.
7
Effect of Adjuvant Homeopathy with Usual Care in Management of Thrombocytopenia Due to Dengue: A Comparative Cohort Study.
Homeopathy. 2019 Aug;108(3):150-157. doi: 10.1055/s-0038-1676953. Epub 2019 Mar 5.
8
Effectiveness of Homeopathic Medicines as Add-on to Institutional Management Protocol for Acute Encephalitis Syndrome in Children: An Open-Label Randomized Placebo-Controlled Trial.顺势疗法药物作为儿童急性脑炎综合征机构管理方案附加疗法的有效性：一项开放标签随机安慰剂对照试验。
Homeopathy. 2018 Aug;107(3):161-171. doi: 10.1055/s-0038-1656715. Epub 2018 Jun 5.
9
Homeopathic Prevention and Management of Epidemic Diseases.流行性疾病的顺势疗法预防与管理
Homeopathy. 2018 Aug;107(3):157-160. doi: 10.1055/s-0038-1649487. Epub 2018 May 12.
10
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.不同干预措施和结局的对照试验中治疗效果估计偏差的实证证据：Meta流行病学研究
BMJ. 2008 Mar 15;336(7644):601-5. doi: 10.1136/bmj.39465.451748.AD. Epub 2008 Mar 3.